Paediatric Insomnia Disorder
Cross-source consensus on Paediatric Insomnia Disorder from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Comparisons
Other
Highlighted claims
- Paediatric insomnia disorder involves sleep initiation, sleep maintenance, or early awakening problems with impaired daytime functioning. — Daridorexant in children and adolescents with insomnia disorder: study protocol for a multicentre randomised controlled trial
- Paediatric insomnia is associated with school, behavioural, quality-of-life, and family burdens. — Daridorexant in children and adolescents with insomnia disorder: study protocol for a multicentre randomised controlled trial
- Approved paediatric pharmacological options for insomnia are limited in Europe and absent in the USA and Canada. — Daridorexant in children and adolescents with insomnia disorder: study protocol for a multicentre randomised controlled trial
- CBT-I is recommended as first-line therapy but may be hard to access or apply in some children. — Daridorexant in children and adolescents with insomnia disorder: study protocol for a multicentre randomised controlled trial